Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation
- PMID: 22854064
- PMCID: PMC3777458
- DOI: 10.5732/cjc.012.10095
Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation
Abstract
Clinical target volume (CTV) delineation is crucial for tumor control and normal tissue protection. This study aimed to define the locoregional extension patterns of nasopharyngeal carcinoma (NPC) and to improve CTV delineation. Magnetic resonance imaging scans of 2366 newly diagnosed NPC patients were reviewed. According to incidence rates of tumor invasion, the anatomic sites surrounding the nasopharynx were classified into high-risk (>30%), medium-risk (5%-30%), and low-risk (<5%) groups. The lymph node (LN) level was determined according to the Radiation Therapy Oncology Group guidelines, which were further categorized into the upper neck (retropharyngeal region and level II), middle neck (levels III and Va), and lower neck (levels IV and Vb and the supraclavicular fossa). The high-risk anatomic sites were adjacent to the nasopharynx, whereas those at medium-or low-risk were separated from the nasopharynx. If the high-risk anatomic sites were involved, the rates of tumor invasion into the adjacent medium-risk sites increased; if not, the rates were significantly lower (P<0.01). Among the 1920 (81.1%) patients with positive LN, the incidence rates of LN metastasis in the upper, middle, and lower neck were 99.6%, 30.2%, and 7.2%, respectively, and skip metastasis happened in only 1.2% of patients. In the 929 patients who had unilateral upper neck involvement, the rates of contralateral middle neck and lower neck involvement were 1.8% and 0.4%, respectively. Thus, local disease spreads stepwise from proximal sites to distal sites, and LN metastasis spreads from the upper neck to the lower neck. Individualized CTV delineation for NPC may be feasible.
Figures
Similar articles
-
Locoregional extension and patterns of failure for nasopharyngeal carcinoma with intracranial extension.Oral Oncol. 2018 Apr;79:27-32. doi: 10.1016/j.oraloncology.2018.02.004. Epub 2018 Feb 22. Oral Oncol. 2018. PMID: 29598947
-
Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation.Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):742-50. doi: 10.1016/j.ijrobp.2008.11.053. Epub 2009 Feb 27. Int J Radiat Oncol Biol Phys. 2009. PMID: 19251378
-
Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):249-56. doi: 10.1016/j.ijrobp.2012.09.003. Epub 2012 Nov 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23200171
-
Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence.BMC Cancer. 2012 Mar 21;12:98. doi: 10.1186/1471-2407-12-98. BMC Cancer. 2012. PMID: 22433671 Free PMC article. Review.
-
Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.Radiat Oncol. 2011 Aug 19;6:97. doi: 10.1186/1748-717X-6-97. Radiat Oncol. 2011. PMID: 21854585 Free PMC article. Review.
Cited by
-
Prognostic value of the fibrinogen albumin ratio index (FARI) in nasopharyngeal carcinoma patients undergoing radiotherapy.Sci Rep. 2023 Nov 23;13(1):20630. doi: 10.1038/s41598-023-48029-0. Sci Rep. 2023. PMID: 37996660 Free PMC article.
-
The boundary of posterior to level V region and the theoretical feasibility of irradiation dose reduction of level Va in nasopharyngeal carcinoma.Sci Rep. 2024 Jan 28;14(1):2308. doi: 10.1038/s41598-024-52857-z. Sci Rep. 2024. PMID: 38280907 Free PMC article.
-
Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation.Radiol Med. 2023 Mar;128(3):362-371. doi: 10.1007/s11547-023-01612-x. Epub 2023 Mar 6. Radiol Med. 2023. PMID: 36877421
-
Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation.Radiat Oncol. 2023 Mar 21;18(1):55. doi: 10.1186/s13014-023-02199-3. Radiat Oncol. 2023. PMID: 36944958 Free PMC article.
-
Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Regional Nodal Metastasis in Nasopharyngeal Carcinoma: Correlation with Nodal Staging.Contrast Media Mol Imaging. 2017 May 29;2017:4519653. doi: 10.1155/2017/4519653. eCollection 2017. Contrast Media Mol Imaging. 2017. PMID: 29097922 Free PMC article.
References
-
- Parkin DM, Whelan SL, Ferlay J, et al. Vol. VIII Lyon: IARC Press; 2002. Cancer incidence in five continents.
-
- Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12–22. - PubMed
-
- Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–1450. - PubMed
-
- Tham IW, Hee SW, Yeo RM, et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy—the national cancer centre Singapore experience. Int J Radiat Oncol Biol Phys. 2009;75:1481–1486. - PubMed
-
- Lin S, Pan J, Han L, et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009;75:1071–1078. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources